Mangrove Partners’s Concentrix CNXC Stock Holding History

Mangrove Partners’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,480	Closed	-$305K	–	166
2025 Q1	$305K	Buy	+5,480	New	+$262K	0.03%	135

Other funds holding CNXC

GBL

Groupe Bruxelles Lambert Brussels, Belgium $240M AUM 50.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mangrove Partners's CNXC Position: Q2 2025 in Review

Mangrove Partners sold out of Concentrix (CNXC) in Q2 2025, closing a stake of 5,480 shares — an estimated $305K sold.

Mangrove Partners first reported a position in CNXC in Q1 2025 and held it in 1 quarter. The position peaked at $305K in Q1 2025. 335 funds tracked by Wall St. Rank hold CNXC as of Q2 2025.

Mangrove Partners reported no remaining Concentrix position as of Q2 2025 after selling out during the quarter.
Mangrove Partners sold 5,480 Concentrix shares in Q2 2025, an estimated $305K.
Mangrove Partners first reported a position in Concentrix in Q1 2025 and held it in 1 quarter.
Mangrove Partners's Concentrix position peaked at $305K in Q1 2025.
335 funds tracked by Wall St. Rank held Concentrix as of Q2 2025.

Based on Mangrove Partners's 13F filing for Q2 2025, filed 14 Aug 2025.